Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

ECCO IBD Curriculum

3.4. Knowledge of complications and appropriate action in terms of investigation and management
Exit StrategiesECCO e-Learning
Year: 2017
Authors: Johan Burisch, Ren Mao, Edyta Szymanska, Glen Doherty

This course has been developed for gastroenterologists, surgeons, paediatricians, pathologists and other interdisciplinary medical experts interested in Inflammatory Bowel Disease(s) (IBD). One major aim of this e-learning activity is to provide evidence-based guidance for clinical practice so that physicians can make informed decisions in partnership with their patients regarding their optimal exit strategies.

After this course you will:

  • To recognise risks, benefits and timing of stopping anti-TNF used as monotherapy or in combination with IM in IBD.
  • To know optimal monitoring following withdrawal of biologic therapy

Diagnosis, anatomy and physiology in IBD11th N-ECCO School
Year: 2020
Authors: Marc Ferrante
Files: 1
US as a decision-making tool in IBDSkills Videos
Year: 2019
Authors: Giovanni Maconi
Endoscopic Assessment of UC Activity with UCEIS e-Coursee-Course
Year: 2016
Authors: Simon Travis, Rebecca Palmer

This course was developed by Professor. Simon Travis and Dr. Rebecca Palmer in cooperation with Leading Edge Medical Education. This course is designed for gastroenterologists, paediatricians, surgeons, nurses and other interdisciplinary medical professional interested in the endoscopy of ulcerative colitis (UC) The intended result of this activity is competence and knowledge of endoscopy, in the assessment and follow-up of patients with UC.  The course is divided into three parts: the first is about the UCEIS and descriptors; the second is Self Assessment, which does not contribute to the final score and the third is the UCEIS Certification itself, to confirm  competence in using the UCEIS.  

Upon completion of this activity learners will:

  • Be trained in the evaluation of endoscopic images in the assessment of activity in UC
  • Understand why UCEIS was developed
  • Understand how UCEIS was developed
  • Understand the role of UCEIS
  • Utilise UCEIS in clinical practice

IBD and Malignancies e-Coursee-Course
Year: 2016
Authors: Larry Egan, Loes Nissen, Gianluca Pellino, Franco Scaldaferri, Edyta Szymanska

This course is designed for gastroenterologists, surgeons, paediatricians, pathologists and other interdisciplinary medical experts interested in Inflammatory Bowel Disease(s) (IBD). One major aim of this e-learning activity is to increase competence and knowledge with regard to IBD and Malignancies and to harmonise diagnostics and treatment in order to improve patient outcomes.

This course will follow the following cases on:

  1. Colorectal cancer in IBD
  2. Lymphoma risk following immunosuppressive therapy with thiopurines in IBD patients - cancer and IBD
  3. Skin cancer in IBD
  4. Chemotherapy in chronically active ulcerative colitis

Upon completion of this activity learners will have gained knowledge on:

  • IBD and Solid Tumours
  • IBD and Haematological Malignancies
  • IBD and Skin Malignancies
  • Management of IBD patients with a past history of malignancy


Stricturing Crohn's Disease e-Coursee-Course
Year: 2016
Authors: Ren Mao, Jessica de Bruyn and Gianluca Pellino, Florian Rieder

This course is designed for gastroenterologists, surgeons, paediatricians, pathologists and other interdisciplinary medical experts interested in Inflammatory Bowel Disease(s) (IBD). One major aim of this e-learning activity is to increase competence and knowledge with regard to the prediction, diagnosis and management of stricturing Crohn's Disease (CD) patients and to harmonise diagnostics and treatment in order to improve patient outcomes.

Upon completion of this activity learners will:

  • Achieve familiarity with predictors of fibrostenosing CD.
  • Understand the role of cross-sectional imaging in the diagnostic work-up of patients with suspected fibrostenosing CD.
  • Understand the current management of fibrostenosing CD.
  • Recognise the therapeutic capabilities of anti-inflammatory therapy, endoscopic dilatation and surgery in the setting of fibrostenosing CD.

Surgery in Crohn's Disease e-Coursee-Course
Year: 2016
Authors: Monica Millan, Chaya Shwaartz, Triana Lobaton, Monica Millan

This course has been developed for gastroenterologists, surgeons, paediatricians, pathologists and other interdisciplinary medical experts interested in Inflammatory Bowel Disease(s) (IBD). One major aim of this e-learning activity is to increase competence and knowledge with regard to the management of CD patients and to harmonise indications and technical considerations for surgery in order to improve patient outcomes.

Upon completion of this activity learners will:

  • - Know how to identify surgical indications in patients with Crohn's Disease (CD)
  • - Be able to adequately treat different complications in CD patients that require surgery
  • - Be able to recommend appropriate changes in perioperative treatment and management

UC Update e-Coursee-Course
Year: 2016
Authors: Gianluca Pellino, Tim Raine, Dominik Bettenworth, Johan Burisch, Kristzina Gecse, Pieter Hindryck, Antonio López-Sanromán

This course is designed for gastroenterologists, surgeons, paediatricians, pathologists and other interdisciplinary medical experts interested in Inflammatory Bowel Disease(s) (IBD). One major aim of this e-learning activity is to increase competence and knowledge with regard to the prediction, diagnosis and management of Ulcerative Colitis (UC) patients and to harmonise diagnostics and treatment in order to improve patient outcomes.

Upon completion of this activity learners will:

  • Have insights into the basic epidemiology of ulcerative colitis
  • Know current treatment options for severe ulcerative colitis, including colectomy
  • Be able to use ciclosporin correctly in severe ulcerative colitis
  • Understand when to order thiopurine methyltransferase (TPMT) activity when starting azathioprine

Surgery in UC e-Coursee-Course
Year: 2015
Authors: André D'Hoore, Marc Ferrante and Anthony de Buck van Overstraeten

This course is designed for gastroenterologists, surgeons, paediatricians, pathologists and other interdisciplinary medical experts interested in Inflammatory Bowel Disease(s) (IBD). The intended result of this activity is increased competence, knowledge, performance and improved patient outcomes.

Upon completion of this activity learners will:

  • Have insights into the position of surgery versus medical therapy in patients with moderate-to-severe as well as acute severe IV steroid refractory colitis (UC)
  • Be able to select the most optimal surgical modalities
  • Gain knowledge on the appropriate follow-up of patients with an ileal pouch-anal anastomosis (IPAA)

Challenges and opportunities of virtual clinics in IBD16th N-ECCO Network Meeting
Year: 2022
Authors: Susanna Jäghult; Revital Barkan; Linn Inganäs
Summary content

1. To understand the opportunities of virtual clinics for both patients and healthcare professionals
2. To get practical examples from two countries of how to implement virtual clinics
3. To get some advice of what to consider and prepare for concerning virtual clinics
4. To hear the patients opinion about virtual clinics

Complications associated with anti-TNF therapy20th IBD Intensive Course for Trainees
Year: 2022
Authors: Yehuda Chowers; Shomron Ben-Horin
Summary content

Learning Objectives - Risks associated with anti-TNF treatments
1. Hypersensitivity reactions
2. Dermatological adverse effects with anti‐TNF therapy
3. Autoimmune‐like disorders
4. Infections and management strategies
5. Malignancy
6. Patients’ selection for anti TNFs vs other biologics

First presentation at the clinic (Tandem talk)6th Basic ECCO: EduCational COurse for Industry
Year: 2022
Authors: Herbert Tilg; Nelly Teix
Summary content

 
Educational objectives:

1. Typical symptoms presented by a patient

2. Epidemiological IBD data from Austria

3. Ulcerative colitis: typical symptoms, endoscopy examples, complications, extraintestinal involvement, differential diagnoses

4. Crohn´s disease: typical symptoms, clinical investigation, typical endoscpy, differential diagnoses, environmental risk factors, extraintestinal complications

Initial work up after diagnosis of IBD (Tandem talk)6th Basic ECCO: EduCational COurse for Industry
Year: 2022
Authors: Susanna Jäghult; Charlotte Rose Hedin
Summary content
  1. To understand the key tests and investigations that complete the work up of the presenting symptoms 
  2. To understand the scope of factors that affect IBD patients and which patients need to be educated about 
  3. To learn the principles of a collaborative approach when initiating a treat-to-target treatment strategy 
  4. To recognise the different factors that affect quality of life for an IBD patient and to develop a patient-centred approach to improvement in quality of life. 
When and how to start biologics?20th IBD Intensive Course for Trainees
Year: 2022
Authors: Gerassimos Mantzaris; Britta Siegmund
Summary content

Learning Objectives:
1. Screening before immunosuppression and immunisation
2. Indications for biological therapy
3. Evaluation of response

IBD patients are eligible to treatment with biologic agents if they have failed or cannot tolerate conventional treatment with corticosteroids and/or immunomodulators (IMMs) or are corticosteroid dependent. Early introduction of biologic therapy is also recommended for patients who at diagnosis have clinical features that predict a disabling course of disease. Ideally, patients should be screened for infectious diseases, malignancies, and complete all essential vaccinations before starting any therapy. Selecting the best biologic amongst the currently available different classes, depends on several patient- and disease-related parameters, such as age, disease activity, comorbidities, and the overall burden of disease. As for any therapy, it is important to define short-, medium- and long-term goals, monitor the progress of disease and adapt treatment accordingly (treat to target).

The first biologic is the best shot. Thus, it is key to adapt dosing to disease activity to avoid primary non-response or partial response and thus achieve a better long-term response. Co-treatment with an IMM may influence the pharmacokinetics in particular of anti-TNF and prevent early development of anti-drug antibodies ADA). Once clinical remission has been achieved, patients should be closely followed by monitoring clinical activity (patient reported outcomes), biomarkers (serum CRP, faecal calprotectin), imaging (US, MRE), endoscopy and/or histology. Treatment optimization in case patient loses response can be achieved either empirically (Standard of Care) by increasing the dose of the biologic or halving the administration interval, or both, or by adding an IMM, or by therapeutic drug monitoring (TDM), i.e., by measuring drug levels and ADA. Pro-active TDM has not been proven superior to reactive TDM, still, it serves to discriminate between pharmacokinetic and pharmacodynamic failure of treatment. However, proactive TDM is increasingly used to achieve clinical response and/or remission during induction, to de-escalate, or stop biologic therapy.

4. Screening before immunosuppression and immunisation
5. Indications for biological therapy
6. Evaluation of response

Identifying Poor Prognosis in CDTalking Heads
Year: 2019
Authors: Mathieu Allez, Tim Raine
Mild Crohn’s disease managementEducational Audio Podcast
Year: 2018
Authors: Matti Waterman
NO002: The quality of care questionnaire – development of a valid measure for persons with Inflammatory Bowel Disease12th N-ECCO Network Meeting
Year: 2018
Authors: Pihl Lesnovska Katarina
N-ECCO_08
Files: 1
Personalising TherapyEducational Audio Podcast
Year: 2018
Authors: Henit Yanai
Save the colon- Early surgery 12th N-ECCO Network Meeting
Year: 2018
Authors: Panis Yves
N-ECCO_11
Files: 1
Perform endoscopy and IBD incl. chromo-endoscopy, balloon dilatation15th IBD Intensive Advanced Course
Year: 2017
Authors: Michetti P., Ferrante M.
stricture dilatation
Files: 1